BNB Plus Corp. (BNBX) Receives Two New Orders for LineaDNA™ from Genetic Medicine Developers
BNB Plus Corp. (BNBX)
Company Research
Source: Business Wire
Provides Updated on BNB Token Holdings and Operating Company Performance NEW YORK--(BUSINESS WIRE)--BNB Plus Corp. (Nasdaq: BNBX) ("BNBX" or the "Company") today announced that its biopharmaceutical subsidiary, LineaRx, Inc. ("LineaRx"), has received two new orders for LineaDNA from well-established developers of genetic medicines. Production and shipment of both orders is expected to be completed prior to June 2026."We're pleased to receive these new orders from leading genetic medicine companies,” said Clay Shorrock, President and CEO of BNBX. “We believe our continued engagements with top-tier customers demonstrates both the technical excellence of our LineaDNA platform and our continued operational execution."The Company also provided a brief corporate update.Enterprise Value and Strong Operating PerformanceLineaRx continues to demonstrate strong operational performance. The Company recently received a $1.2 million accelerated LineaDNA order, representing the largest LineaDNA o
Show less
Read more
Impact Snapshot
Event Time:
BNBX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BNBX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BNBX alerts
High impacting BNB Plus Corp. news events
Weekly update
A roundup of the hottest topics
BNBX
News
- BNB Plus: Fiscal Q1 Earnings Snapshot [Yahoo! Finance]Yahoo! Finance
- BNB Plus Corp. (BNBX) Appoints James Haft as Independent Board DirectorBusiness Wire
- Applied Dna Sciences (NASDAQ:BNBX) is now covered by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>. They set a "sell (e+)" rating on the stock.MarketBeat
- BNB Plus Corp. (BNBX) to Present at the Digital Asset Virtual Investor Conference January 27thBusiness Wire
- BNB Plus Corp. (BNBX) to Present at the Digital Asset Virtual Investor Conference January 27thGlobeNewswire
BNBX
Sec Filings
- 2/13/26 - Form 4
- 2/13/26 - Form 3
- 2/13/26 - Form SCHEDULE
- BNBX's page on the SEC website